Table 3.
Adjusted risk estimates of overall survival
| Multivariate analysis | |||||
|---|---|---|---|---|---|
| Parity groupa | Number of cases | Adjusted HRb,c | 95 % CI | p | 5-Year survival (%) |
| PABC <5 | N = 86 | 2.65 | 1.09–6.42 | 0.03 | 65.8 |
| Parous ≥5 | N = 172 | 1.52 | 0.71–3.28 | 0.28 | 77.5 |
| Nulliparous | N = 76 | 1.0 | – | – | 98.0 |
Hazard ratios and 95 % confidence intervals for all covariates included in the final model are described in Table 7 in the supplemental material. Clinical characteristics of the collapsed Parous ≥5 group can be viewed in Table 8 in the supplemental material
Parous ≥5 cases diagnosed five years or later from last childbirth
aPABC <5 cases had a mean followup time of 3.0 ± 2.9 years. Mean followup time for nulliparous was 3.6 ± 3.6 years and 3.9 ± 3.7 years for cases diagnosed ≥5
bAdjusted for tumor biologic subtype, clinical stage, and year of diagnosis
cHistologic subtype and grade were not univariately significant and were thus not included in the final multivariate models